| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EZFL | Common Stock | Purchase | $45,591 | +20,263 | +27.5% | $2.25 | 94,026 | 02 Dec 2021 | Direct | F1 |
| transaction | EZFL | Common Stock | Purchase | $568 | +254 | +0.27% | $2.24 | 94,280 | 02 Dec 2021 | Direct | F2 |
| transaction | EZFL | Common Stock | Purchase | $3,472 | +1,523 | +1.62% | $2.28 | 95,803 | 02 Dec 2021 | Direct | F3 |
| transaction | EZFL | Common Stock | Purchase | $39,240 | +18,000 | +18.8% | $2.18 | 113,803 | 03 Dec 2021 | Direct | F4 |
| holding | EZFL | Common Stock | 186,010 | 02 Dec 2021 | Cameo Life Sciences Investments LLC | F5 |
| Id | Content |
|---|---|
| F1 | The 20,263 shares the Reporting Person purchased on December 2, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife. |
| F2 | The 254 shares the Reporting Person purchased on December 2, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife. |
| F3 | The 1,523 shares the Reporting Person purchased on December 2, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife. |
| F4 | The 18,000 shares the Reporting Person purchased on December 3, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife. |
| F5 | Jack Levine is the Manager of Cameo Life Sciences Investments LLC and beneficially owns 186,010 shares of common stock, which are held by Cameo Life Sciences Investments, LLC. |